New TB vaccine trial launches: could this be the key to preventing tuberculosis?
NCT ID NCT06050356
First seen Jan 31, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests a new vaccine called H107e/CAF®10b to see if it is safe and can help the body fight tuberculosis (TB). The vaccine is made from parts of the TB bacteria and an adjuvant that boosts the immune system. It is the first time this vaccine is given to people, involving 140 healthy adults aged 18 to 45. The goal is to prevent TB disease, so people would not need antibiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurum Institute
Pretoria, Gauteng, 0028, South Africa
Conditions
Explore the condition pages connected to this study.